Skip to main content

Table 3 Proportion of patients with reduction in total fibroid volume at 6 months

From: The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China

Reduction in total fibroid volume (%) Peking (N = 58) Xi’an (N = 49) Overall (N = 107)
≥10 0.90 (0.79, 0.96) 0.96 (0.86, 1.00) 0.93 (0.86, 0.97)
≥20 0.89 (0.77, 0.96) 0.87 (0.74, 0.95) 0.88 (0.80, 0.94)
≥30 0.76 (0.62, 0.87) 0.74 (0.59, 0.86) 0.75 (0.65, 0.83)
≥40 0.69 (0.54, 0.80) 0.52 (0.37, 0.67) 0.61 (0.51, 0.71)
≥50 0.46 (0.33, 0.60) 0.30 (0.18, 0.46) 0.39 (0.29, 0.49)